Coherus Biosciences reported $420.46M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Aerie Pharmaceuticals AERI:US $ 234.53M 6.34M
Akebia Therapeutics AKBA:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 36010M 2788M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Coherus Biosciences CHRS:US $ 420.46M 11.68M
Endo International Ordinary Shares ENDP:US $ 8057.5M 9.85M
Fujifilm 4901:JP Y 247101M 99050M
Horizon Pharma HZNP:US $ 2552.74M 2.49M
JAZZ PHA JAZZ:US $ 5992.87M 32.34M
LG Chem 051910:KS KW 10323993M 964661M
Merk MRK:US $ 30586M 104M
Myriad Genetics MYGN:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 20.84B 777M
Zoetis ZTS:US $ 6592M 0M